S. LATOUR

408 total citations
3 papers, 331 citations indexed

About

S. LATOUR is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, S. LATOUR has authored 3 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Public Health, Environmental and Occupational Health, 2 papers in Genetics and 1 paper in Pathology and Forensic Medicine. Recurrent topics in S. LATOUR's work include Inflammatory Bowel Disease (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Peripheral Neuropathies and Disorders (1 paper). S. LATOUR is often cited by papers focused on Inflammatory Bowel Disease (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Peripheral Neuropathies and Disorders (1 paper). S. LATOUR collaborates with scholars based in Canada, Switzerland and Germany. S. LATOUR's co-authors include Yves Théorêt, Carmelo Cuffari, Carmen Cuffari, Ernest G. Seidman, William Camu and Dieter Poehlau and has published in prestigious journals such as Gut, Canadian Journal of Physiology and Pharmacology and Patient Preference and Adherence.

In The Last Decade

S. LATOUR

3 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. LATOUR Canada	3	249	168	77	61	48	3	331
Carmelo Cuffari United States	7	267 1.1×	237 1.4×	112 1.5×	76 1.2×	55 1.1×	11	412
Y Touze France	2	325 1.3×	247 1.5×	109 1.4×	81 1.3×	84 1.8×	2	464
Scott A. Hande United States	6	319 1.3×	274 1.6×	137 1.8×	63 1.0×	52 1.1×	6	436
Pascale Catala France	1	321 1.3×	240 1.4×	102 1.3×	81 1.3×	84 1.8×	2	449
El-Monsor Shobowale–Bakre United Kingdom	7	340 1.4×	112 0.7×	54 0.7×	63 1.0×	121 2.5×	10	444
Emilia Escuredo United Kingdom	5	247 1.0×	80 0.5×	57 0.7×	49 0.8×	112 2.3×	9	400
Monica Arenas-Hernandez United Kingdom	9	142 0.6×	120 0.7×	54 0.7×	33 0.5×	47 1.0×	13	311
Dirk P. van Asseldonk Netherlands	12	229 0.9×	221 1.3×	144 1.9×	41 0.7×	40 0.8×	22	410
Phillip Minar United States	12	44 0.2×	317 1.9×	207 2.7×	23 0.4×	70 1.5×	40	434
Ruud Beukers Netherlands	8	17 0.1×	171 1.0×	144 1.9×	35 0.6×	11 0.2×	10	290

Countries citing papers authored by S. LATOUR

Since Specialization

Citations

This map shows the geographic impact of S. LATOUR's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. LATOUR with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. LATOUR more than expected).

Fields of papers citing papers by S. LATOUR

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. LATOUR. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. LATOUR. The network helps show where S. LATOUR may publish in the future.

Co-authorship network of co-authors of S. LATOUR

This figure shows the co-authorship network connecting the top 25 collaborators of S. LATOUR. A scholar is included among the top collaborators of S. LATOUR based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. LATOUR. S. LATOUR is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Camu, William, et al.. (2010). Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study. Patient Preference and Adherence. 4. 127–127. 3 indexed citations

2.

Cuffari, Carmelo, et al.. (1996). 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.. Gut. 39(3). 401–406. 265 indexed citations

3.

Cuffari, Carmen, Ernest G. Seidman, S. LATOUR, & Yves Théorêt. (1996). Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy. Canadian Journal of Physiology and Pharmacology. 74(5). 580–585. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact